急性心肌梗死患者GRACE评分与实验室指标的相关性

杨利娇, 王虹, 丁振江, 等. 急性心肌梗死患者GRACE评分与实验室指标的相关性[J]. 临床心血管病杂志, 2017, 33(2): 142-146. doi: 10.13201/j.issn.1001-1439.2017.02.010
引用本文: 杨利娇, 王虹, 丁振江, 等. 急性心肌梗死患者GRACE评分与实验室指标的相关性[J]. 临床心血管病杂志, 2017, 33(2): 142-146. doi: 10.13201/j.issn.1001-1439.2017.02.010
YANG Lijiao, WANG Hong, DING Zhenjiang, et al. Correlation of GRACE score and laboratory index in patients with acute myocardial infarction[J]. J Clin Cardiol, 2017, 33(2): 142-146. doi: 10.13201/j.issn.1001-1439.2017.02.010
Citation: YANG Lijiao, WANG Hong, DING Zhenjiang, et al. Correlation of GRACE score and laboratory index in patients with acute myocardial infarction[J]. J Clin Cardiol, 2017, 33(2): 142-146. doi: 10.13201/j.issn.1001-1439.2017.02.010

急性心肌梗死患者GRACE评分与实验室指标的相关性

详细信息
    通讯作者: 王虹,E-mail:wanghong3721@163.com
  • 中图分类号: R542.2

Correlation of GRACE score and laboratory index in patients with acute myocardial infarction

More Information
  • 目的:研究急性心肌梗死(AMI)患者GRACE评分与实验室检查指标间的相关性。方法:回顾性分析2014-01-2016-09我院心内科收治的AMI患者186例,其中ST段抬高型心肌梗死(STEMI)125例(STEMI组),非ST段抬高型心肌梗死(NSTEMI)61例(NSTEMI组)。计算患者入院时GRACE评分,并将患者分为低危组、中危组、高危组。收集患者一般资料和实验室指标,分析GRACE评分与实验室指标间的相关性。结果:年龄、性别、饮酒史、红细胞压积、GRACE评分在STEMI组与NSTEMI组间差异有统计学意义(P<0.05),根据GRACE评分、红细胞压积、年龄绘制ROC曲线下面积分别为0.626[95%可信区间(CI):0.538~0.713,P<0.01]、0.633(95%CI: 0.542~0.724,P<0.01)、0.665(95%CI:0.578~0.752,P<0.01),3者联合起来ROC曲线下面积为0.678(95%CI:0.592~0.763,P<0.01)。性别、吸烟、饮酒史、D-二聚体、纤维蛋白原降解产物、红细胞压积、红细胞分布宽度、红细胞平均体积、年龄在GRACE评分低、中、高危组间差异有统计学意义(P<0.05),相关性分析显示,D-二聚体、纤维蛋白降解产物、红细胞压积、红细胞分布宽度、红细胞平均体积、血小板压积、血小板平均体积、年龄与GRACE评分的相关性差异有统计学意义(P<0.05),多元线性回归显示年龄和纤维蛋白原降解产物与GRACE评分独立相关。结论:STEMI组与NSTEMI组患者年龄、性别、饮酒史、红细胞压积、GRACE评分间有差别,实验室检查指标与GRACE评分间有明显相关性。
  • 加载中
  • [1]

    吴彩军,李春盛.D-二聚体检测对急性冠脉综合征早期诊断意义的探讨[J].中国急救医学,2010,30(12):1071-1073.

    [2]

    TENEKECIOGLU E,YILMAZ M,YONTAR O C,et al.Red blood cell distribution width is associated with myocardial injury in non-ST-elevation acute coronary syndrome[J].Clinics(Sao Paulo),2015,70:18-23.

    [3]

    TUFANO A,CIMINO E,DI MINNO M N,et al.Diabetes mellitus and cardiovascular prevention:the role and the limitations of currently available antiplatelet drugs[J].Int J Vasc Med,2011,2011:250518.

    [4]

    ELBAROUNI B,GOODMAN S G,YAN R T,et al.Validation of the Global Registry of Acute Coronary Event(GRACE)risk score for in-hospital mortality in patients with acute coronary syndrome in Canada[J].Am Heart J,2009,158:392-399.

    [5]

    SAIGO M,HSUE P Y,WATERS D D.Role of thrombotic and fibrinolytic factors in acute coronary syndromes[J].Prog Cardiovasc Dis,2004,46:524-538.

    [6]

    WANNAMETHEE S G,WHINCUP P H,SHAPER A G,et al.Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death,but not angina pectoris,in older men[J].J Thromb Haemost,2009,7:1605-1611.

    [7]

    MAPLE-BROWN L J,CUNNINGHAM J,NANDI N,et al.Fibrinogen and associated risk factor in a high-risk population:urban indigenous australians,the druid Study[J].Cardiovasc Diabetol,2010,24:225-228.

    [8]

    LIPPI G,FILIPPOZZI L,MONTAGNANA M,et al.Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute coronary syndromes[J].Clin Chem Lab Med,2009,47:353-357.

    [9]

    HOU Y,CARRIM N,WANG Y,et al.Platelets in hemostasis and thrombosis:Novel mechanisms of fibrinogen-independent platelet aggregation and fibronectinmediated protein wave of hemostasis[J].J Biomed Res,2015,29:437-444.

    [10]

    DE LUCA G,SECCO G G,VEFDOIA M,et al.Combination between mean platelet volume and platelet distribution width to predict the prevalence and extent of coronary artery disease;results form a large cohort study[J].Blood Coagu Fibrinolysis,2014,25:86-91.

    [11]

    BRUNZELL J D,DAVIDSON M,FURBERG C D,et al.Lipoprotein management in patients with cardiometabolic risk:consensus statement from the American Diabetes Association and the American College of Cardiology Foundation[J].Diabetes Care,2008,31:811-822.

    [12]

    LAMARCHE B,MOORJANI S,LUPIEN P J,et al.Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study[J].Circulation,1996,94:273-278.

    [13]

    GOTTO A M JR,WHITNEY E,STEIN E A,et al.Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study(AFCAPS/TexCAPS)[J].Circulatio,2000,101:477-484.

    [14]

    周琦,王归圣,王归真.不同年龄男性急性心肌梗死患者的临床特点对比研究[J].实用心脑肺血管病杂志,2011,19(1):6-7.

  • 加载中
计量
  • 文章访问数:  240
  • PDF下载数:  66
  • 施引文献:  0
出版历程
收稿日期:  2016-09-22

目录